Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ce mark entities : Boston scientific corporation save search
At 4.37% CAGR, Medical Electrodes Market Size to hit USD 1715.8 Million in 2028, Says Brandessence Market Research
Published: 2022-03-14 (Crawled : 12:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GE | News | $148.06 -3.19% 0.0% 9.5M
|
Electronic Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: -1.29%
H: 0.0%
C: 0.0%
NTUS | $32.96 0.09% 0.0%
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
ce mark research
Global Endoscopy Device Market (2021 to 2026) - Featuring Arthrex, Conmed and Olympus Among Others
Published: 2021-08-27 (Crawled : 22:00) - prnewswire.com
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
| Email alert
Add to watchlist
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
| Email alert
Add to watchlist
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
| Email alert
Add to watchlist
endoscopy ce mark device
Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope
Published: 2021-05-25 (Crawled : 12:00) - biospace.com/
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.49%
H: 0.77%
C: 0.05%
ce mark
Surge in Demand for Lithotripsy for Non-invasiveness, Low Risk of Failure Creates Opportunities in Lithotripsy Device Market, Innovations of Laser-based Products to Expand Growth Vistas, TMR
Published: 2021-05-19 (Crawled : 16:00) - prnewswire.com
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -1.22%
H: 0.57%
C: 0.41%
laser risk ce mark growth device
Pharmaceutical and Life Sciences Real World Evidence Market Outlook 2021-2030: Comparison of Randomized Clinical Trials and Real World Evidence
Published: 2021-05-04 (Crawled : 18:00) - prnewswire.com
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: -0.39%
clinical trials ce mark life science trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.